Home Depot's stock sits near a 52-week low and housing turnover has been frozen for four years, yet the company keeps writing dividend checks. Whether that streak survives depends on three numbers investors should watch closely.

Our 24/7 Wall St. price target for ON Semiconductor (NASDAQ:ON | ON Price Prediction) is $95.90 over the next 12 months. That points to 24.23% upside from the current $77.20 share price.

New York, New York--(Newsfile Corp. - September 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DICK'S Sporting Goods, Inc. (NYSE: DKS) between September 8, 2025 and August 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline. SO WHAT: If you purchased DICK'S Sporting Goods common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New York, New York--(Newsfile Corp. - September 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Costco just posted another strong quarter, proving its all-weather appeal. After 22 years of dividend hikes, Costco could pay a record one-time distribution later this year.

Pros use superior tools to trade IPO events like lockup expirations, leaving most retail investors at a disadvantage. Long-term investors may benefit from waiting out early volatility in the SpaceX IPO and focusing on business fundamentals.

Several major foreign banks have expressed their interest in a possible ​merger or combination with Switzerland's UBS , a ‌Swiss newspaper said on Sunday.

Palisade Bio NASDAQ: PALI said it is advancing its lead drug candidate, PALI-2108, into Phase II studies for ulcerative colitis and Crohn's disease after completing its Phase I program.

Qualcomm just posted 61% automotive growth and raised its non-handset target to $40 billion, yet the market keeps valuing it like a company living and dying by smartphone chips. Something in that gap is worth a closer look.

Mansi Khetani, CFO of ChargePoint (CHPT), says the EV-based company "outperformed on all fronts" when discussing earnings. "People are buying EVs," she says, explaining that lower initial costs for these vehicles are winning over consumers as gas-based cars, and gasoline prices as a whole, climb.